T. Rowe Price Investment Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,108
Closed -$151K 901
2025
Q4
$151K Buy
3,108
+619
+25% +$30.7K ﹤0.01% 659
2025
Q3
$118K Buy
2,489
+782
+46% +$37.7K ﹤0.01% 660
2025
Q2
$83K Buy
+1,707
New +$87.2K ﹤0.01% 662

Other funds holding SNY

T. Rowe Price Investment Management's SNY Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 3,108 shares — an estimated $151K sold.

T. Rowe Price Investment Management first reported a position in SNY in Q2 2025 and held it in 3 quarters. The position peaked at $151K in Q4 2025. 744 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 3,108 Sanofi shares in Q1 2026, an estimated $151K.
  • T. Rowe Price Investment Management first reported a position in Sanofi in Q2 2025 and held it in 3 quarters.
  • T. Rowe Price Investment Management's Sanofi position peaked at $151K in Q4 2025.
  • 744 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.